Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:2776-2782
Published online before print May 23, 2005, doi: 10.1161/CIRCULATIONAHA.104.483024
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v111,pe443)
Right arrow All Versions of this Article:
111/21/2776    most recent
CIRCULATIONAHA.104.483024v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devuyst, G.
Right arrow Articles by Bogousslavsky, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devuyst, G.
Right arrow Articles by Bogousslavsky, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Carotid Artery Disease
*Ultrasound
Related Collections
Right arrow Carotid Stenosis
Right arrow Imaging
Right arrow Doppler ultrasound, Transcranial Doppler etc.

(Circulation. 2005;111:2776-2782.)
© 2005 American Heart Association, Inc.


Imaging

Ultrasound Measurement of the Fibrous Cap in Symptomatic and Asymptomatic Atheromatous Carotid Plaques

Gérald Devuyst, MD; Patrick Ruchat, MD; Theodoros Karapanayiotides, MD; Lisa Jonasson, MS; Olivier Cuisinaire, PhD; Johannes-Alexander Lobrinus, MD; Marc Pusztaszeri, MD; Askenadios Kalangos, MD; Paul-André Despland, MD; Jean-Philippe Thiran, PhD; Julien Bogousslavsky, MD

From the Department of Neurology (G.D., T.K., P.-A.D., J.B.), Division of Neuropathology (J.-A.L., M.P.), and Department of Cardiovascular Surgery (P.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Signal Processing Institute (L.J., O.C., J.-P.T.), Swiss Federal Institute of Technology, Lausanne, Switzerland; and Department of Cardiovascular Surgery, Geneva University Hospital (A.K.), Geneva, Switzerland.

Correspondence to Gérald Devuyst, MD, Department of Neurology, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, 1011 Lausanne, Switzerland. E-mail gerald.devuyst{at}chuv.hospvd.ch

Received June 8, 2004; revision received January 25, 2005; accepted February 22, 2005.

Background— Fibrous cap thickness (FCT) is an important determinant of atheroma stability. We evaluated the feasibility and potential clinical implications of measuring the FCT of internal carotid artery plaques with a new ultrasound system based on boundary detection by dynamic programming.

Methods and Results— We assessed agreement between ultrasound-obtained FCT values and those measured histologically in 20 patients (symptomatic [S]=9, asymptomatic [AS]=11) who underwent carotid endarterectomy for stenosing (>70%) carotid atheromas. We subsequently measured in vivo the FCT of 58 stenosing internal carotid artery plaques (S=22, AS=36) in 54 patients. The accuracy in discriminating symptomatic from asymptomatic plaques was assessed by receiver operating characteristic curves for the minimal, mean, and maximal FCT. Decision FCT thresholds that provided the best correct classification rates were identified. Agreement between ultrasound and histology was excellent, and interobserver variability was small. Ultrasound showed that symptomatic atheromas had thinner fibrous caps (S versus AS, median [95% CI]: minimal FCT=0.42 [0.34 to 0.48] versus 0.50 [0.44 to 0.53] mm, P=0.024; mean FCT=0.58 [0.52 to 0.63] versus 0.79 [0.69 to 0.85] mm, P<0.0001; maximal FCT=0.73 [0.66 to 0.92] versus 1.04 [0.94 to 1.20] mm, P<0.0001). Mean FCT measurement demonstrated the best discriminatory accuracy (area under the curve [95% CI]: minimal 0.74 [0.61 to 0.87]; mean 0.88 [0.79 to 0.97]; maximal 0.82 [0.71 to 0.93]). The decision threshold of 0.65 mm (mean FTC) demonstrated the best correct classification rate (82.8%; positive predictive value 75%, negative predictive value 88.2%).

Conclusions— FCT measurement of carotid atheroma with ultrasound is feasible. Discrimination of symptomatic from asymptomatic plaques with mean FCT values is good. Prospective studies should determine whether this ultrasound marker is reliable.


Key Words: ultrasonics • plaque • carotid arteries • atherosclerosis • cerebrovascular disorders




This article has been cited by other articles:


Home page
StrokeHome page
J. N. Redgrave, P. Gallagher, J. K. Lovett, and P. M. Rothwell
Critical Cap Thickness and Rupture in Symptomatic Carotid Plaques: The Oxford Plaque Study
Stroke, June 1, 2008; 39(6): 1722 - 1729.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Karapanayiotides
Letter by Karapanayiotides Regarding Article, "Histological Assessment of 526 Symptomatic Carotid Plaques in Relation to the Nature and Timing of Ischemic Symptoms: the Oxford Plaque Study"
Circulation, November 21, 2006; 114(21): e598 - e598.
[Full Text] [PDF]


Home page
StrokeHome page
T. Karapanayiotides and G. Devuyst
Fibrous Cap Thickness and Stability of Carotid Atheromata
Stroke, October 1, 2006; 37(10): 2451 - 2451.
[Full Text] [PDF]


Home page
StrokeHome page
Z.-Y. Li, T. Tang, S. P.S. Howarth, and J. H. Gillard
Response to Letter by Karapanayiotides and Devuyst
Stroke, October 1, 2006; 37(10): 2452 - 2452.
[Full Text] [PDF]


Home page
StrokeHome page
T. Karapanayiotides and J. Bogousslavsky
Carotid Stenosis: Looking Beyond the Lumen With Ultrasound
Stroke, July 1, 2006; 37(7): 1646 - 1646.
[Full Text] [PDF]


Home page
StrokeHome page
B. A. Wasserman, R. J. Wityk, H. H. Trout III, and R. Virmani
Response to Letter by Karapanayiotides et al
Stroke, July 1, 2006; 37(7): 1647 - 1647.
[Full Text] [PDF]